influenza-a-virus

Documents about influenza-a-virus

• A Study of Influenza Virus Vaccines in Children and Adults#906293ClinicalTrials.gov
• Occurrence of influenza antivirals and resistance development in influenza A viruses in aquatic environments: A risk assessment#1040243PLOS
• Study of Fluzone® Influenza Virus Vaccines 2012-2013 Formulation Among Adults.#967072ClinicalTrials.gov
• Virus Shedding and Environmental Deposition of a Novel Influenza Virus#1382655ClinicalTrials.gov
• Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children#1372069ClinicalTrials.gov
• Safety and Reactogenicity of a H1N1 Influenza Challenge Virus in Healthy Volunteers#890955ClinicalTrials.gov
• Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine#867649ClinicalTrials.gov
• Collection and Extraction of Respiratory Specimens#1244077ClinicalTrials.gov
• Assessing spatial transmission risk of respiratory infectious diseases across cities of different socioeconomic tiers in China: A modelling study#385432PLOS
• Safety Study of Avian Flu Vaccine#1408063ClinicalTrials.gov
• Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Adult Subjects#1419417ClinicalTrials.gov
• Influenza Virus - A Multicenter Registry#892393ClinicalTrials.gov
• Study of Immune Responses After Vaccination Against Seasonal Influenza Virus and Against Influenza H1N1-v Pandemic Virus in a Medical Staff.#833779ClinicalTrials.gov
• A Phase 2 Study to Evaluate Immune Responses of FluMist®#828303ClinicalTrials.gov
• Study of Intradermal Quadrivalent Influenza Vaccine in Adults Aged 18 Through 64 Years#867243ClinicalTrials.gov
• Safety and Immunogenicity of Live Attenuated Influenza H5N2#1031774ClinicalTrials.gov
• Banlangen Granules Anti-seasonal Influenza Study#1101930ClinicalTrials.gov
• Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults#152480ClinicalTrials.gov
• Alveolar Macrophages Are Essential for Protection from Respiratory Failure and Associated Morbidity following Influenza Virus Infection#281612OpenAlex
• Safety and Efficacy of an H1N1 Influenza Vaccine in People With Asthma#1349412ClinicalTrials.gov
• Detection of Influenza A, Influenza B, and RSV Using the Liat™ Assays on the Liat™ Analyzer#1085812ClinicalTrials.gov
• A Study in Healthy Adults to Assess Priming With Antigenically Mismatched Live Attenuated A/H7N3 Influenza Virus Vaccine Followed by Inactivated A/H7N9 Influenza Virus Vaccine#1103258ClinicalTrials.gov
• Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intradermal Route)#829475ClinicalTrials.gov
• A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults#162533ClinicalTrials.gov
• A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Children#467620ClinicalTrials.gov
• Lactylation in influenza a virus infection: Current evidence, knowledge gaps, and future perspectives#651915Europe PMC
• Study of Fluzone® Influenza Virus Vaccine 2011-2012 Formulation (Intramuscular Route) Among Adults#893941ClinicalTrials.gov
• MAVS is important for antiviral defense against influenza A virus in a human respiratory epithelium model#255560PLOS
• Phase I Clinical Trial of Quadrivalent Influenza Virus Split Vaccine#181601ClinicalTrials.gov
• Incidence of respiratory syncytial virus and influenza: A Danish nationwide cohort study#5093Europe PMC
• Rechallenge With a Low Pathogenicity Avian H10N7 Influenza Virus in Healthy Human Volunteers Previously Challenged With H10N7 Influenza#885049ClinicalTrials.gov
• Monomeric Nucleoprotein of Influenza A Virus#1329116HAL (France)
• A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine#897789ClinicalTrials.gov
• Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test#1421758ClinicalTrials.gov
• Pathogenicity and zoonotic potential of a novel pdm09-lineage H1N2 swine influenza A virus spatiotemporally linked to transboundary pig trade#1538833PLOS
• Low Pathogenicity Avian H10N7 Influenza Virus in a Healthy Human Challenge Model#1365644ClinicalTrials.gov
• Safety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy Adults#1296003ClinicalTrials.gov
• Host Genetic Susceptibility to Avian Influenza A/H5N1#1032806ClinicalTrials.gov
• CFD Modeling of Influenza Virus Diffusion During Coughing and Breathing in A Ventilated Room#940251Journal of Thermal Engineering
• Study of Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation#1140879ClinicalTrials.gov
• Influenza A Virus RNA Polymerase Is Enriched on the Chromatin of Innate Immune Response Genes#1120279HAL (France)
• Human iPSC-based Alveolus-on-Chip reveals immunometabolic regulation of influenza A virus infection by Butyrate#1247038Dbt
• Evaluation of the Safety and Immunogenicity of a Live Attenuated Virus Vaccine for the Prevention of H2N3 Influenza#1408977ClinicalTrials.gov
• Early Immune Responses to Inactivated Influenza Vaccine: a Pilot Study#141089ClinicalTrials.gov
• Influenza situation in the Eastern Mediterranean Region: W33/2021 (from 15/08/2021 to 21/08/2021): source of data: EMFLU Network and FLUMART#435424WHO IRIS
• H5N1 Vaccine Study in Japanese Adults#834783ClinicalTrials.gov
• Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth#903226ClinicalTrials.gov
• A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 Months#895475ClinicalTrials.gov
• Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses#876921ClinicalTrials.gov
• A Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above#158053ClinicalTrials.gov